HPLC-RIF法研究罗格列酮在中国2型糖尿病患者体内的多剂量药动学特点
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Study HPLC-RIF on multiple-dose pharmacokinetics of rosiglitazonein Chinese patients with type 2 diabetes
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |